| scholarly article | Q13442814 |
| P2093 | author name string | Sam Dagogo-Jack | |
| Ben Brannick | |||
| P2860 | cites work | Economic costs of diabetes in the U.S. in 2012 | Q22241287 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis | Q24629045 | ||
| Treatment of prediabetes | Q26783350 | ||
| A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses | Q26799686 | ||
| Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention | Q26822066 | ||
| Genetic determinants of variability in glycated hemoglobin (HbA(1c)) in humans: review of recent progress and prospects for use in diabetes care | Q27026664 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies | Q28036762 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Effect of valsartan on the incidence of diabetes and cardiovascular events | Q28275975 | ||
| Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine | Q29614199 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study | Q29615122 | ||
| Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome | Q29616853 | ||
| Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes | Q29619192 | ||
| Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis | Q30240765 | ||
| Obesity and dyslipidemia | Q30406189 | ||
| Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes | Q30548796 | ||
| The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years | Q30577414 | ||
| Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study | Q30781389 | ||
| A Self-assessment Tool for Screening Young Adults at Risk of Type 2 Diabetes Using Strong Heart Family Study Data | Q31118956 | ||
| Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight | Q33291269 | ||
| Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the pathobiology of prediabetes in a biracial cohort (POP-ABC) study | Q33570090 | ||
| Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk | Q33793843 | ||
| The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus | Q33853759 | ||
| XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients | Q33974818 | ||
| Effect of ramipril on the incidence of diabetes | Q33999592 | ||
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial | Q33999757 | ||
| Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. | Q34006689 | ||
| Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota | Q34057383 | ||
| Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study | Q34073458 | ||
| Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease | Q44954014 | ||
| Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk | Q45069543 | ||
| Diabetes, prediabetes, and glycemic control in the United States: challenges and opportunities | Q45130454 | ||
| The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study | Q45222106 | ||
| Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. | Q45915250 | ||
| Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). | Q46092514 | ||
| Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. | Q46093100 | ||
| Decline in physical activity in black girls and white girls during adolescence | Q46142415 | ||
| Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients | Q46150735 | ||
| Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study | Q46570649 | ||
| Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. | Q46582998 | ||
| Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus | Q46654868 | ||
| Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke | Q46805650 | ||
| The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). | Q46878587 | ||
| Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters | Q46988914 | ||
| Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes | Q47372410 | ||
| Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial | Q48589819 | ||
| Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. | Q50577664 | ||
| Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. | Q51105072 | ||
| Increased fasting glucose and the prevalence of arterial stiffness: a cross-sectional study in Chinese adults. | Q51148843 | ||
| Pioglitazone for diabetes prevention in impaired glucose tolerance. | Q51161029 | ||
| Serum Markers of Endothelial Dysfunction and Inflammation Increase in Hypertension with Prediabetes Mellitus. | Q51284763 | ||
| A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. | Q51296605 | ||
| Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. | Q51470684 | ||
| American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. | Q51555562 | ||
| Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. | Q51556387 | ||
| Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. | Q51562831 | ||
| Is there a glycemic threshold for mortality risk? | Q51563307 | ||
| Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? | Q51615482 | ||
| Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. | Q54277408 | ||
| Prevention of Diabetes With Mediterranean Diets | Q56627460 | ||
| Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe) | Q73095398 | ||
| Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes | Q74373048 | ||
| The postprandial state and risk of cardiovascular disease | Q77736532 | ||
| Cost-effectiveness of diabetes education | Q80930759 | ||
| Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty | Q81580410 | ||
| Diabetes and peripheral arterial disease in men: trends in prevalence, mortality, and effect of concomitant coronary disease | Q84415832 | ||
| β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment | Q87843093 | ||
| Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia | Q38026380 | ||
| Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. | Q38894567 | ||
| Awareness of Prediabetes and Engagement in Diabetes Risk-Reducing Behaviors | Q38993768 | ||
| Medical school-based teaching kitchen improves HbA1c, blood pressure, and cholesterol for patients with type 2 diabetes: Results from a novel randomized controlled trial | Q39263193 | ||
| A Comparison of Biological and Physical Risk Factors for Cardiovascular Disease in Overweight/Obese Individuals With and Without Prediabetes | Q39611562 | ||
| Global healthcare expenditure on diabetes for 2010 and 2030. | Q39899138 | ||
| High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study | Q40247912 | ||
| Subclinical Disease Burden as Assessed by Whole-Body MRI in Subjects With Prediabetes, Subjects With Diabetes, and Normal Control Subjects From the General Population: The KORA-MRI Study | Q40414887 | ||
| Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. | Q40619323 | ||
| Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose | Q40639755 | ||
| MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study | Q40682012 | ||
| Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis | Q41145484 | ||
| The Prediabetic State, Its Nature and Consequences—A Look Toward the Future | Q41545408 | ||
| Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease | Q41640163 | ||
| Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm! | Q42409296 | ||
| Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum | Q42948845 | ||
| Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study | Q42982910 | ||
| Effect of nateglinide on the incidence of diabetes and cardiovascular events | Q43130181 | ||
| Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective | Q43534782 | ||
| Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial | Q43606926 | ||
| Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients | Q43705651 | ||
| Pathogenesis of NIDDM. A balanced overview | Q43832606 | ||
| Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study | Q43861373 | ||
| Disorders of glucose metabolism in acute stroke patients: an underrecognized problem | Q44001514 | ||
| Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study | Q44007368 | ||
| Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis | Q44276019 | ||
| Ischemic stroke in prediabetic patients. | Q44392355 | ||
| Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial | Q44396155 | ||
| The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging | Q44453020 | ||
| The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes | Q44481535 | ||
| Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke | Q44580066 | ||
| Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program | Q34195798 | ||
| Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose | Q34204855 | ||
| Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program | Q34335544 | ||
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin | Q34335548 | ||
| Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage | Q34345083 | ||
| Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study | Q34503055 | ||
| Preventing diabetes-related morbidity and mortality in the primary care setting | Q34748971 | ||
| Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status | Q35189249 | ||
| Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study. | Q35225391 | ||
| Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels | Q35390039 | ||
| Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride | Q35579114 | ||
| Predicting diabetes: our relentless quest for genomic nuggets | Q35688272 | ||
| Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus | Q35999587 | ||
| Vascular disease in pre-diabetes: new insights derived from systems biology | Q36005577 | ||
| Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). | Q36076414 | ||
| Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. | Q36426708 | ||
| Macrovascular complication phenotypes in type 2 diabetic patients | Q36572131 | ||
| Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study | Q36707166 | ||
| Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome. | Q36728465 | ||
| Dietary habits and leisure-time physical activity in relation to adiposity, dyslipidemia, and incident dysglycemia in the pathobiology of prediabetes in a biracial cohort study | Q36790618 | ||
| Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes | Q36805400 | ||
| Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies | Q36839519 | ||
| Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program | Q36862877 | ||
| Pioglitazone after Ischemic Stroke or Transient Ischemic Attack | Q36953272 | ||
| Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. | Q37067155 | ||
| Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications | Q37106937 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Ethnic differences in glycemic markers in patients with type 2 diabetes | Q37193435 | ||
| Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose | Q37212324 | ||
| Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms | Q37347210 | ||
| Prediabetes: a high-risk state for diabetes development. | Q37476370 | ||
| Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence | Q37719077 | ||
| Metabolic syndrome, prediabetes and the science of primary prevention | Q37868921 | ||
| Preventing diabetes mellitus in developing countries | Q38001362 | ||
| P433 | issue | 1 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 33-50 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction | |
| P478 | volume | 47 |
| Q90479826 | Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older |
| Q64231228 | Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels |
| Q90151768 | Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model |
| Q89966279 | Bredemolic Acid Improves Cardiovascular Function and Attenuates Endothelial Dysfunction in Diet-Induced Prediabetes: Effects on Selected Markers |
| Q92857324 | Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial |
| Q88917877 | Gender-specific differences of interaction between cadmium exposure and obesity on prediabetes in the NHANES 2007-2012 population |
| Q92093343 | Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank |
| Q91633787 | Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis |
| Q90655369 | Regression from prediabetes to normal glucose regulation: State of the science |
| Q91759548 | SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice |
Search more.